Related Experiment Video
Updated: Jan 8, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Digitalizing Risk Minimization Measures in EU: Explorative Co-design Workshops with Expert Stakeholders
Mathias Møllebæk1, Amalie Christine Bagger1, Kirstine Lund Hansen1
1Copenhagen Centre for Regulatory Science, Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100, Copenhagen, Denmark.
Digitalizing medicines safety information in the EU offers personalized interventions but requires addressing implementation, workload, and ethical challenges. Future strategies must consider digital access and diverse information ecosystems for effective risk minimization.
Area of Science:
- Pharmacovigilance and Drug Safety
- Digital Health Technologies
- Health Policy and Regulation
Background:
- Traditional medicines safety measures like package leaflets are evolving with digital technologies.
- Limited strategic discussion exists on digitalizing additional risk minimization measures.
- Digital tools are crucial for accessing medicines information for patients and healthcare professionals.
Purpose of the Study:
- To gather expert stakeholder visions for digital risk minimization in the EU.
- To explore policy and healthcare implications of future digital risk minimization technologies.
Main Methods:
- Co-design workshops involving diverse stakeholders (clinicians, regulators, industry, IT, legal experts) across three EU member states.
- Thematic analysis of workshop transcripts and visual products through two coding cycles.
Main Results:
- Digitalization transforms roles, responsibilities, and collaborations for effective and sustainable digital solutions.
- Implementation pathways must adapt to diverse EU information ecosystems and digital access by patients and professionals.
- Remote monitoring may empower patients as data subjects, introducing new ethical and legal considerations.
Conclusions:
- Digital risk minimization in the EU presents opportunities for timely, personalized interventions.
- Implementation complexity, healthcare professional workload, and patient ethics are key challenges.
- Focused policy deliberation and research in digital health are warranted.
More Related Videos
08:33A Cross-Disciplinary and Multi-Modal Experimental Design for Studying Near-Real-Time Authentic Examination Experiences
Published on: September 4, 2019
08:58Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
Published on: October 17, 2025
Related Concept Videos
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:
Design Consideration
The factor of safety is another key...